statistiche ricercatore

Continente	#
AS - Asia	440
EU - Europa	300
NA - Nord America	242
SA - Sud America	50
Continente sconosciuto - Info sul continente non disponibili	27
AF - Africa	10
OC - Oceania	2
Totale	1.071

Nazione	#
US - Stati Uniti d'America	233
SG - Singapore	171
RU - Federazione Russa	119
VN - Vietnam	103
IT - Italia	92
CN - Cina	88
BR - Brasile	44
DE - Germania	28
HK - Hong Kong	24
BD - Bangladesh	17
FR - Francia	16
FI - Finlandia	14
JP - Giappone	10
KR - Corea	8
GB - Regno Unito	7
IN - India	5
NL - Olanda	5
ZA - Sudafrica	5
CZ - Repubblica Ceca	4
MX - Messico	4
TH - Thailandia	4
AR - Argentina	3
AT - Austria	2
AU - Australia	2
BE - Belgio	2
ID - Indonesia	2
PH - Filippine	2
PL - Polonia	2
TT - Trinidad e Tobago	2
UA - Ucraina	2
AM - Armenia	1
BG - Bulgaria	1
CA - Canada	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CL - Cile	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EE - Estonia	1
IE - Irlanda	1
IQ - Iraq	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MA - Marocco	1
NE - Niger	1
NO - Norvegia	1
PK - Pakistan	1
SE - Svezia	1
SN - Senegal	1
TR - Turchia	1
TW - Taiwan	1
TZ - Tanzania	1
Totale	1.044

Nome	#
Early impairment in mitochondrial quality check and function precedes the development of cardiac phenotypes in an mouse model of Fabry Disease	176
Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation [*Boccella N., Paolillo R. and Coretti L. co-first authors]	167
514 ATAXIA TELANGIECTASIA MUTATED PROTEIN MODULATES GLUCOSE AND LIPID METABOLISM IN THE HEART	142
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology	136
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy	126
Ataxia-Telangiectasia Mutated protein protects cardiac cells from stress by rewiring glucose metabolism	115
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy	108
[Lights and shadows of combined epigenomic and transcriptomic profiling to identify novel diagnostic, prognostic or therapeutic targets for cardiovascular diseases.]	79
null	22
Totale	1.071

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	24	0	0	0	1	1	3	2	4	0	3	5	5
2022/2023	14	2	0	0	0	0	1	1	4	1	2	1	2
2023/2024	56	6	7	8	10	2	8	0	1	1	1	5	7
2024/2025	311	12	0	2	4	10	17	44	22	8	31	129	32
2025/2026	619	73	61	66	59	104	15	58	20	89	38	11	25
2026/2027	43	15	28	0	0	0	0	0	0	0	0	0	0
Totale													1.071